Page last updated: 2024-08-24

simendan and Aortic Valve Stenosis

simendan has been researched along with Aortic Valve Stenosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Fredholm, M; Houltz, E; Jörgensen, K; Ricksten, SE2
Gooi, A; Karl, T; Pandey, R; Ramakrishnan, K1
Acea, AB; Ferrer Hita, JJ; García-González, MJ; Jiménez-Sosa, A; Jorge-Pérez, P; Lacalzada Almeida, JB1
Baddour, AJ; Tagarakis, GI; Tsilimingas, NB1
Flaim, BD; MacIsaac, AI; Prior, DL; Yii, MY1
Hoefer, D; Hoermann, C; Jonetzko, P; Laufer, G; Poelzl, G1
Bech-Hanssen, O; Houltz, E; Jörgensen, K; Ricksten, SE1
Jirmar, R; Kolesar, M; Nejedly, M; Vanek, T1

Trials

4 trial(s) available for simendan and Aortic Valve Stenosis

ArticleYear
Levosimendan or milrinone for right ventricular inotropic treatment?-A secondary analysis of a randomized trial.
    Acta anaesthesiologica Scandinavica, 2020, Volume: 64, Issue:2

    Topics: Aged; Aged, 80 and over; Aortic Valve; Aortic Valve Stenosis; Cardiotonic Agents; Female; Heart Valve Prosthesis Implantation; Heart Ventricles; Humans; Male; Middle Aged; Milrinone; Prospective Studies; Simendan; Stroke Volume

2020
Inotropic and lusitropic effects of levosimendan and milrinone assessed by strain echocardiography-A randomised trial.
    Acta anaesthesiologica Scandinavica, 2018, Volume: 62, Issue:9

    Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Cardiac Output; Cardiotonic Agents; Catheterization, Peripheral; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography, Transesophageal; Female; Heart; Heart Rate; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Pulmonary Wedge Pressure; Simendan; Stroke Volume

2018
Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    Cardiovascular therapeutics, 2015, Volume: 33, Issue:4

    Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Cardiovascular Agents; Critical Illness; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Recovery of Function; Severity of Illness Index; Simendan; Spain; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2015
Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
    Circulation, 2008, Feb-26, Volume: 117, Issue:8

    Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Blood Pressure; Cardiotonic Agents; Diastole; Echocardiography; Female; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertrophy, Left Ventricular; Male; Mitral Valve; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vascular Resistance; Ventricular Function, Left

2008

Other Studies

5 other study(ies) available for simendan and Aortic Valve Stenosis

ArticleYear
Use of β-blockade and levosimendan for separation from extracorporeal life support in an infant with postoperative diastolic dysfunction.
    World journal for pediatric & congenital heart surgery, 2013, Volume: 4, Issue:4

    Topics: Adrenergic beta-Antagonists; Aortic Valve Stenosis; Cardiotonic Agents; Diastole; Drug Therapy, Combination; Extracorporeal Circulation; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Infant, Newborn; Male; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction; Ventricular Outflow Obstruction

2013
Can pulmonary artery hypertension be attributed to levosimendan? A problematic based on a patient's case.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2010, Volume: 11, Issue:7

    Topics: Aged; Aortic Valve Stenosis; Blood Pressure; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Hypertension, Pulmonary; Pulmonary Artery; Pyridazines; Simendan

2010
Pre-operative use of levosimendan in two patients with severe aortic stenosis and left ventricular dysfunction.
    Heart, lung & circulation, 2006, Volume: 15, Issue:1

    Topics: Aged; Aortic Valve Stenosis; Cardiotonic Agents; Coronary Artery Bypass; Coronary Artery Disease; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Ventricular Dysfunction, Left

2006
Successful administration of levosimendan in a patient with low-gradient low-output aortic stenosis.
    Wiener klinische Wochenschrift, 2006, Volume: 118, Issue:1-2

    Topics: Aged; Aortic Valve Stenosis; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Male; Perioperative Care; Pyridazines; Severity of Illness Index; Simendan; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left

2006
Rescue peri-operative management of the patient with giant electrical storm and severe left ventricular dysfunction: support by levosimendan and intraaortic balloon counterpulsation.
    Interactive cardiovascular and thoracic surgery, 2008, Volume: 7, Issue:4

    Topics: Aortic Valve Stenosis; Cardiac Pacing, Artificial; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Echocardiography; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Male; Middle Aged; Perioperative Care; Pyridazines; Simendan; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left

2008